Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oncternal Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 94.7K | $47K | $0.50 | Jun 14, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ONCT | Oncternal Therapeutics, Inc. | Jun 12, 2023 | 2 | $9.82K | 4 | Jun 14, 2023 | Chief Scientific Officer |
ONCT | Oncternal Therapeutics, Inc. | Feb 21, 2023 | 1 | $0 | 4 | Feb 23, 2023 | Chief Scientific Officer |
ONCT | Oncternal Therapeutics, Inc. | Jan 3, 2023 | 1 | -$6.39K | 4 | Jan 5, 2023 | Chief Scientific Officer |
ONCT | Oncternal Therapeutics, Inc. | Jul 28, 2022 | 2 | $0 | 4 | Aug 1, 2022 | Chief Scientific Officer |
ONCT | Oncternal Therapeutics, Inc. | Jan 20, 2022 | 1 | $0 | 4 | Jan 24, 2022 | Chief Scientific Officer |
ONCT | Oncternal Therapeutics, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Chief Scientific Officer |